A Danish study also found that more men with ischemic heart disease are taking both nitrates and a phosphodiesterase type 5 (PDE5) inhibitor, with the prescription rate increasing 20-fold from 2000 to 2018.
Home-based, physical therapist-led behavior change program boosted walking distance in patients with PAD
The randomized trial, which connected patients with intermittent claudication due to peripheral artery disease (PAD) with physical therapists, found an increase in mean six-minute walk distance but no improvement in patient-reported quality of life.
Retrospective data from Israel showed that in people ages 60 years and older, an additional booster dose of the Pfizer-BioNTech COVID-19 vaccine was 55% effective against symptomatic disease and 68% effective against hospitalization.
Courses to help ACP members prepare for the ABIM Board Exam will take place May 23 to 27 in Greater Chicago and July 11 to 15 in the Washington, D.C., area. Virtual formats are available for both courses.